AveX­is wins the in­side track at the FDA with gene ther­a­py ‘break­through’

Chica­go-based AveX­is has lined up the lat­est break­through ther­a­py des­ig­na­tion from the FDA, gain­ing an in­side track at the agency for its ear­ly-stage gene …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.